Michael Hurlston left the role of Director at Astera Labs, Inc., effective November 3, 2026. As of November 6, 2026, Astera Labs, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on November 4, 2026, naming 1 departure (Form 8-K, November 4, 2026).
Astera Labs, Inc. announced the departure of its Director on Nov 4. 30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Astera Labs, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Astera Labs, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-11-04. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Astera Labs, Inc. files it.
Also on the record for Astera Labs, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 7, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 9.1% of the class | 5%+ stakes | Source |
| July 27, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 7.4% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| January 21, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 6.2% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by Gajendra Sanjay | 4.5% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by Mohan Jitendra | 5.4% of the class | 5%+ stakes | Source |
| October 17, 2025 | Stake report, Schedule 13G, by BlackRock, Inc. | 5.02% of the class | 5%+ stakes | Source |
| August 13, 2025 | Stake report, Schedule 13G/A, by AllianceBernstein L.P. | 3.9% of the class | 5%+ stakes | Source |
| July 29, 2025 | Stake report, Schedule 13G/A, by The Vanguard Group | 7.3% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Astera Labs, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Astera Labs, Inc. and the records around it.
Astera Labs, Inc. elsewhere on the record
Companies that share a holder
- AllianceBernstein L.P. also filed stake reports on 82 other companies: New Fortress Energy Inc (Nov 2026), RIVERNORTH OPPORTUNITIES FUND, INC. (Oct 2026), Trex Co Inc (Sep 2026)
- FMR LLC also filed stake reports on 761 other companies: ASPEN NEUROSCIENCE INC (Nov 2026), AVALO THERAPEUTICS INC (Nov 2026), BRAZE INC (Nov 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
Watch Astera Labs, Inc.
Get an email when Astera Labs, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Astera Labs, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Astera Labs, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Astera Labs, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
10 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-11-04 | Out | Director | 2026-11-03 | 8-K, 2026-11-04 |
Who leads Astera Labs, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Michael Hurlston, departure reported, effective 2026-11-03 (filed 2026-11-04). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Astera Labs, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Astera Labs, Inc., with the record behind each one.
Find candidates like Director at Astera Labs, Inc.Every change, in the filing's words
Departing: Michael Hurlston, Director, effective 2026-11-03
On November 2, 2026, Michael Hurlston notified Astera Labs, Inc. (the "Company") of his resignation as a member of the Board of Directors of the Company and any committees thereof, effective November 3, 2026.
- There were no disagreements between Mr. Hurlston and the Company, and his resignation was not related to the Company's operations, policies or practices.
Tools for this story
Each opens in a new tab, filled in for Astera Labs, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.